GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » ROA %

Labiana Health (XMAD:LAB) ROA % : -22.09% (As of Dec. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Labiana Health's annualized Net Income for the quarter that ended in Dec. 2022 was €-15.02 Mil. Labiana Health's average Total Assets over the quarter that ended in Dec. 2022 was €67.97 Mil. Therefore, Labiana Health's annualized ROA % for the quarter that ended in Dec. 2022 was -22.09%.

The historical rank and industry rank for Labiana Health's ROA % or its related term are showing as below:

XMAD:LAB's ROA % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.575
* Ranked among companies with meaningful ROA % only.

Labiana Health ROA % Historical Data

The historical data trend for Labiana Health's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health ROA % Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
ROA %
1.63 -2.64 -13.85

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
ROA % - - -4.00 -22.09

Competitive Comparison of Labiana Health's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labiana Health's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's ROA % distribution charts can be found below:

* The bar in red indicates where Labiana Health's ROA % falls into.



Labiana Health ROA % Calculation

Labiana Health's annualized ROA % for the fiscal year that ended in Dec. 2022 is calculated as:

ROA %=Net Income (A: Dec. 2022 )/( (Total Assets (A: Dec. 2021 )+Total Assets (A: Dec. 2022 ))/ count )
=-8.943/( (68.367+60.779)/ 2 )
=-8.943/64.573
=-13.85 %

Labiana Health's annualized ROA % for the quarter that ended in Dec. 2022 is calculated as:

ROA %=Net Income (Q: Dec. 2022 )/( (Total Assets (Q: Jun. 2022 )+Total Assets (Q: Dec. 2022 ))/ count )
=-15.016/( (75.163+60.779)/ 2 )
=-15.016/67.971
=-22.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2022) net income data. ROA % is displayed in the 30-year financial page.


Labiana Health  (XMAD:LAB) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2022 )
=Net Income/Total Assets
=-15.016/67.971
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-15.016 / 57.574)*(57.574 / 67.971)
=Net Margin %*Asset Turnover
=-26.08 %*0.847
=-22.09 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2022) net income data. The Revenue data used here is two times the semi-annual (Dec. 2022) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Labiana Health ROA % Related Terms

Thank you for viewing the detailed overview of Labiana Health's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Labiana Health (XMAD:LAB) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.